Vischer has acted as legal counsel to TargImmune Therapeutics, a private Swiss-based biotechnology firm, on the closing of its 2021 financing round, raising CHF 17.7 million. The Vischer legal team was led by Matthias Staehelin (pictured) with Francesca Pesenti and Nicolai Bleskie
Meyer Burger successfully placed newly issued shares raising gross proceeds of CHF 80 million and EUR 145 million green guaranteed senior unsecured convertible bonds. The bonds were issued by a German subsidiary and guaranteed by Meyer Burger Technology. The convertible bonds are convertible into shares of Meyer
Dec Group, a global provider of contained powder handling systems has acquired the Extract Technology business from U.S- based Wabash National Corporation, a company listed on the New York Stock Exchange. Extract Technology is a provider of containment and aseptic
Zurich based generics company, Fairmed Healthcare, which is majority owned by Strides Pharma Global, announced that it has raised €10 million in senior secured financing from Duke Royalty. Urbach Law acted as transaction counsel for Fairmed Healthcare and Strides Pharma Global.
Raiffeisen Schweiz Genossenschaft, a Swiss systemically relevant bank, issued AT1 Bonds in the total amount of CHF 300 million. With a base tranche of CHF 200 million on 31 March 2021 and a first reopening of CHF 100 million on 1 July 2021. Homburger
Québec issued CHF 250 million Bonds. Deutsche Bank London Branch, acting through Deutsche Bank Zurich Branch acted as Lead Manager. The Bonds will be listed on the SIX Swiss Exchange. Homburger advised Deutsche Bank Zurich Branch with a team led by partner René Bösch (capital markets, pictured) and